Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

See Locations Near You

Summary

This randomized pilot clinical trial studies health care coach support in reducing acute care use and cost in patients with cancer. Health care coach support may help cancer patients to make decisions about their care that matches what is important to them with symptom management.

View Full Description

Full Description

PRIMARY OBJECTIVES:

I. To reduce acute care utilization by 2-5% for advanced cancer patients by training and deploying health care coaches who help patients and families discuss care goals, virtual modalities, engage in shared-decision-making, and participate in educational activities.

SECONDARY OBJECTIVES:

I. To improve patients' experience of their care. II. Improve patient understanding of advanced care planning. III. To improve the receipt of goal concordant care. IV. To reduce total healthcare costs.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM A: Patients receive usual care.

ARM B: Patients undergo health care coach support with a baseline introduction (either telephonic or in-person) of the program followed by a visit (telephonic or in-person) with the health care coach after the first oncology appointment to discuss goals of care. The health care coach will contact patient based on patients' ongoing needs (weekly to monthly) and will conduct symptom assessments based on patients' treatment plans and symptoms.

After completion of study, patients are followed up for 6 months.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Newly diagnosed patients for the following conditions

Colon cancer stage III and IV
Rectal cancer stage II, III, IV
Glioblastoma multiforme (brain) -- no stage
Non-small cell lung cancer stage IIIA, IIIB, IV
Small cell lung cancer, limited stage and extensive stage
Castration-resistant prostate cancer
Head and neck cancer stage III and IV
Gastric cancer stage III and IV
Esophageal cancer stage III and IV
Pancreatic cancer stage II, III, IV
Renal cell carcinoma, stage IV
Breast cancer, stage IV, if triple negative ER/PR/H2N negative or on systemic chemotherapy
Sarcoma, stage IV
Bladder carcinoma, stage IV
Acute myeloid leukemia
Melanoma, stage III and IV
Ovarian cancer, stage III and IV
High grade myelodysplastic syndrome (MDS)
Any patient with recurrent or progressive cancer
Patients must have the ability to understand and willingness to sign a written informed consent document
Patient must have ongoing oncologic needs and plan to receive all care at the study institution and not already be in hospice or home-care

Exclusion Criteria:

Patients must have capacity to consent
Pregnant patients are excluded

Study is for people with:

Breast Cancer

Estimated Enrollment:

128

Study ID:

NCT03154190

Recruitment Status:

Active, not recruiting

Sponsor:

Stanford University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Virginia K Crosson Cancer Center
Fullerton California, 29835, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

128

Study ID:

NCT03154190

Recruitment Status:

Active, not recruiting

Sponsor:


Stanford University

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider